43
Participants
Start Date
June 30, 2011
Primary Completion Date
April 30, 2014
Study Completion Date
April 30, 2014
Levosimendan
Levosimendan was administered according to a standardized treatment protocol. A total dose of 12.5mg or 25mg (corresponding to one or two ampoules) was given at an infusion rate of 0.05 μg/kg/min to 0.2μg/kg/min with or without a loading dose (6 μg/kg or 3 μg/kg over 10 minutes). The decision about total dose, infusion rate and loading dose was at the discretion of the treating physician.
University of Zurich
OTHER